血栓性微血管病
ADAMTS13号
医学
血栓性血小板减少性紫癜
非典型溶血尿毒综合征
人口
胃肠病学
内科学
肾
急性肾损伤
复合杂合度
基因检测
透析
免疫学
微血管病
分裂细胞
肾移植
病理
肾活检
基因型
伊库利珠单抗
皮肤病科
外显子组测序
微血管病性溶血性贫血
儿科
活检
肾脏疾病
新鲜冰冻血浆
临床意义
作者
Sumedh Jayanti,Esther Ting,Seethalakshmi Viswanathan,Noha A. Elserafy,James Clark,Luiza Steffens Reinhardt,Andrew Ziolkowsk,Katie Ashton,Muralikrishna Gangadharan Komala
出处
期刊:Kidney360
[Lippincott Williams & Wilkins]
日期:2026-07-01
卷期号:7 (10): 2375-2378
标识
DOI:10.34067/kid.0000001302
摘要
Hereditary thrombotic thrombocytopenic purpura (TTP) is a rare autosomal recessive disorder caused by ADAMTS13 deficiency, typically presenting in childhood or early adulthood. We describe an atypical presentation of hereditary TTP in a 55-year-old man presenting with AKI on a background of diabetic kidney disease, without suggestive history or identifiable triggers. Initial evaluation revealed features of thrombotic microangiopathy (TMA), including hemolysis, thrombocytopenia, with preserved coagulation parameters. Presumptive complement-mediated TMA was treated with eculizumab; however, the patient progressed to dialysis dependence and developed transient neurologic symptoms. ADAMTS13 activity was reduced (8 U/dl) without a detectable inhibitor, prompting treatment with fresh frozen plasma (FFP), which resulted in hematologic and neurologic improvement. Kidney biopsy demonstrated acute TMA superimposed on advanced diabetic and vascular disease. Genetic testing identified a heterozygous pathogenic ADAMTS13 variant (c.587C>T; p.Thr196Ile) without a second pathogenic allele. Additional long-read sequencing detected polymorphisms that may be associated with reduced ADAMTS13 activity; however, current evidence suggests that these are variants of unknown significance. Although these variants have been associated with variation in ADAMTS13 levels in population or functional studies, the contribution of the additional variants remains uncertain. Functional response to FFP with transient correction of ADAMTS13 levels supported a diagnosis of hereditary TTP. The patient was commenced on regular FFP infusions and has been stable without further hematologic or neurologic events. He remains dialysis dependent, awaiting kidney transplantation. This case highlights a late-onset, atypical presentation of hereditary TTP and raises important questions regarding the pathogenicity of heterozygous variants and modifying polymorphisms. It underscores the need to consider ADAMTS13 deficiency in unexplained TMA and kidney failure, even in the absence of classic features or biallelic mutations.
科研通智能强力驱动
Strongly Powered by AbleSci AI